Kisspeptin recombinant oral vaccine: A master gene vaccine inhibiting the reproductive physiology and behavior of ram lambs

Publication date: Available online 31 October 2017
Source:Vaccine
Author(s): Birhanu Tesema, Jia-yu Zhao, Xun-pin Jiang, Gui-qiang Liu, Yan-guo Han, Teketay Wassie
The KISS1 gene product, kisspeptin, stimulates gonadotrophic steroid hormone (GNRH) neuronal signaling through the G-protein coupled receptor, kiss1r. Disturbance of this signaling pathway causes hypogonadotropic hypogonadism in mammals. As part of this cutting-edge research project, we analyzed the efficacy of an oral kisspeptin recombinant vaccine on the reproductive physiology and behavior of ram lambs. Ten 56-day old ram lambs were randomly divided into treatment and control groups to receive the experimental recombinant vaccines, C500/pKS-asd or C500/pVAX-asd (aspartate-β semialdehyde dehydrogenase), respectively. The vaccines were orally administered at 14-day intervals (days 0, 14, 28, 42, 56, 70, and 84) and at each time point, blood samples were taken and scrotal circumference data recorded for each animal. At the end of the experimental period, day 98, sexual behaviors were assessed, scrotal circumferences were measured, and blood samples were collected. Testicular samples were also collected after the animals were sacrificed. Anti-kisspeptin antibody and testosterone serum levels were measured by indirect ELISA. Results demonstrated that the levels of anti-kisspeptin antibodies were significantly higher in the treatment group compared to controls (P<0.05). However, serum testosterone levels were lower in the treatment group (P<0.05). Interestingly, vaccine administration contributed to a significant reduction (P<0.05) in sexual behavior propensity. These results suggest that the kisspeptin recombinant oral vaccine regulates and inhibits the reproductive physiology and behavior of ram lambs.



http://ift.tt/2htBaIj